Drug Type Fusion protein |
Synonyms- |
Target |
Action agonists |
Mechanism FGF21R agonists |
Therapeutic Areas |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| Diabetes Mellitus, Type 2 | Preclinical | Netherlands | 20 Sep 2022 | |
| Metabolic Dysfunction Associated Steatohepatitis | Preclinical | Netherlands | 20 Sep 2022 |






